Sofwave Medical specializes in non-invasive aesthetic medical solutions to improve skin laxity, provide lifting effects, and enhance muscle toning. Utilizing its proprietary Synchronous Ultrasound Parallel Beam Technology (SUPERB™), the Sofwave product delivers controlled ultrasound energy to the mid-dermal layer, stimulating collagen and elastin production and improving skin appearance with minimal downtime. Clinically validated and supported by multiple broad FDA clearances, Sofwave's technologies offer effective solutions for patients seeking aesthetic enhancements without invasive procedures. The introduction of the Pure Impact add-on module expands Sofwave's product portfolio, offering increased treatment versatility and efficiency to address a broader range of aesthetic concerns. Pure Impact is the world’s first plyometric muscle activation and toning device, emulating complex, compound full-body muscle movements. Sofwave Plus Pure Impact is the ultimate complement to GLP-1 weight loss drugs. As these medications help with weight loss, Sofwave + Pure Impact ensures no muscle loss, increased tone, and decreased overall laxity, providing a comprehensive solution for enhancing physical appearance and health. Backed by strong clinical data and regulatory endorsements, Sofwave Medical represents a significant opportunity for investors in a rapidly growing market segment.